We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
The Beachbody Company
BODI
$74.8M
| $284K | ﹤0.01% |
10,811
-377
| -3% | -$16.4K |
|
|
AKYA
2952
DELISTED
Akoya BioSciences
AKYA
| $283K | ﹤0.01% |
29,620
| – | – |
|
|
CAN
2953
Canaan Creative
CAN
$159M
| $283K | ﹤0.01% |
137,500
-56,600
| -29% | -$157K |
|
|
VIA
2954
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $282K | ﹤0.01% |
8,681
-1,702
| -16% | -$53.5K |
|
2955
NextNav
NN
$2.23B
| $281K | ﹤0.01% |
95,894
-9,399
| -9% | -$28.9K |
|
2956
Spok Holdings
SPOK
$241M
| $281K | ﹤0.01% |
+34,287
| New | +$278K |
|
2957
Relmada Therapeutics
RLMD
$527M
| $280K | ﹤0.01% |
80,158
-5,951
| -7% | -$52.3K |
|
2958
Playboy Inc
PLBY
$141M
| $278K | ﹤0.01% |
101,105
-7,232
| -7% | -$25.9K |
|
2959
Lifetime Brands
LCUT
$211M
| $276K | ﹤0.01% |
36,360
-8,361
| -19% | -$64.5K |
|
|
BBIG
2960
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| $276K | ﹤0.01% |
29,684
-2,665
| -8% | -$41K |
|
|
LSEA
2961
DELISTED
Landsea Homes
LSEA
| $275K | ﹤0.01% |
52,688
| – | – |
|
2962
Hycroft Mining Holding Corp
HYMC
$2.47B
| $274K | ﹤0.01% |
51,508
-2,168
| -4% | -$13.8K |
|
2963
PepGen
PEPG
$197M
| $273K | ﹤0.01% |
20,391
+8,734
| +75% | +$113K |
|
|
PVBC
2964
DELISTED
Provident Bancorp
PVBC
| $272K | ﹤0.01% |
37,337
-7,364
| -16% | -$74.7K |
|
|
WHWK
2965
Whitehawk Therapeutics
WHWK
$271M
| $268K | ﹤0.01% |
20,913
| – | – |
|
2966
Atlanticus Holdings
ATLC
$1.52B
| $267K | ﹤0.01% |
10,195
| – | – |
|
|
SNPO
2967
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
| $267K | ﹤0.01% |
36,061
-14,473
| -29% | -$133K |
|
2968
CS Disco
LAW
$279M
| $265K | ﹤0.01% |
41,942
-10,195
| -20% | -$87.1K |
|
|
VLTA
2969
DELISTED
Volta Inc.
VLTA
| $265K | ﹤0.01% |
745,163
-60,965
| -8% | -$46.3K |
|
|
VWE
2970
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
| $264K | ﹤0.01% |
81,073
-4,972
| -6% | -$15.2K |
|
2971
Silvercrest Asset Management
SAMG
$79.9M
| $263K | ﹤0.01% |
14,019
| – | – |
|
2972
Prime Medicine
PRME
$559M
| $262K | ﹤0.01% |
+14,128
| New | +$255K |
|
2973
Celularity
CELU
$20.3M
| $260K | ﹤0.01% |
20,197
+1,510
| +8% | +$27.8K |
|
2974
MPLX
MPLX
$59.7B
| $257K | ﹤0.01% |
+7,830
| New | +$256K |
|
2975
OppFi
OPFI
$803M
| $257K | ﹤0.01% |
125,238
+14,567
| +13% | +$32.8K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.